BOCA RATON, Fla., Nov. 19, 2013 /PRNewswire/ -- Biotest Pharmaceuticals Corporation ("Biotest"), a wholly owned US subsidiary of Biotest AG, (Dreieich Germany), announced today that it has been awarded the 2013 International Business Leadership Award for "Business Expansion" from the Greater Miami Chamber of Commerce. This award recognizes companies that uniquely focus on retaining and growing existing international business relationships and whose activities provide a significant impact on the Florida economy.
"We are pleased to be recognized by the community for our commitment to producing high quality biotherapeutic products that improve and save lives. Expanding our US operations is an important element of Biotest AG's strategy to address the global demands for our products," stated Jordan Siegel, Biotest's Chief Executive Officer, "I'd like to thank the entire Biotest team for their hard work and dedication to make our corporate expansion successful."
Biotest researches and manufactures biotherapeutic products with a specialization in immunology and hematology. The company applies high-quality standards throughout the process, beginning with the recruitment of donors for the plasma collected in dedicated plasmapheresis centers, through the manufacturing processes, to the final products delivered to patients. Biotest currently employs around 900 people in the U.S., approximately 500 of whom work in the state of Florida.
The plasma collected from Biotest's centers is used as the critical raw material for the FDA-licensed biological products manufactured in the Boca Raton facility: BIVIGAM [Immune Globulin Intravenous (Human), 10% Liquid] and Nabi-HB® [Hepatitis B Immune Globulin (Human)]. These products are utilized by healthcare facilities throughout the U.S.
Biotest has invested more than $60 million in the last five years to expand and modernize its U.S. manufacturing facility in Boca Raton, and expand its U.S. plasma collection network.
About Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals Corporation was created as a wholly-owned US subsidiary of Biotest AG in December 2007. Innovative technologies and a sharp focus on safety are incorporated into every facet of the business. From plasma collection to product manufacturing and distribution – from nature for life – Biotest Pharmaceuticals Corporation is committed to maintaining high standards of excellence. For more information please visit www.biotestpharma.com.
|SOURCE Biotest Pharmaceuticals Corporation|
Copyright©2012 PR Newswire.
All rights reserved